Chemical, Pharmaceutical and Biotechnological Industry in Latvia

21.1 Manufacture of basic pharmaceutical products

Enterprise Europe Network (Profile:BRUK20211105001)

Type: 
Cooperation
Short description of advertisement: 
UK healthcare company is looking for small ( 5mm dia x 2mm d) gold plated N35 - 3800 gauss neodymium magnets and gold plated 800gauss ferrite magnet. The magnets will be used to reduce symptoms of the menopause.

A growing UK healthcare company, specialised in acupuncture is selling small magnets to patients to reduce symptons of the menopause. The magnet is placed on the skin using a medical grade sticker. The product is already on the market but they are looking for a new supplier of gold-plated ferrite magnets and gold plated neodymium magnets.

Magnet dimensions 5mm diameter, 2mm depth.

The company is looking specifically for:
- gold plated N35 - 3800 gauss neodymium magnets and
- gold plated 800gauss ferrite magnet 

The supplier will need to provide documented assurance that the composition of the  magnets is as described without any extras added.
The gold plated layer needs to be 14k gold so it is hypoallergenic. 

The UK company is looking to sign supplier or manufacturing agreement. The supplier does not need to supply both types of magnets.

Order quantity: 600 magnets in total. Types of magnets to be determined.

 

For more information please contact Enterprise Europe Network Latvia.

Contact person: 
Enterprise Europe Network Latvia
Contact languages: 
English
Country: 
United Kingdom
Address: 
Perses Street 2, Riga, LV-1442, Latvia
Phone: 
+371-67039430
Fax: 
+371-67039431
E-mail: 
info [at] een.lv
Proposal valid till: 
Friday, 11 November, 2022

PHARMIDEA LTD

General Information
Registration number: 
4000379117
Year of foundation: 
2005
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1 Manufacture of basic pharmaceutical products
21.10 Manufacture of basic pharmaceutical products
Number of employees: 
51 - 100
Turnover (EUR):
5 000 001 - 10 000 000
2019
5 000 001 - 10 000 000
2018
Export volume (EUR):
5 000 001 - 10 000 000
2019
5 000 001 - 10 000 000
2018
Export countries: 
Colombia
Croatia
Czech Republic
Ecuador
Estonia
Finland
France
Germany
Ireland
Israel
Kazakhstan
Libya
Malaysia
Mexico
Morocco
Philippines
Portugal
Russia
Saudi Arabia
Spain
Sweden
Switzerland
Taiwan
Thailand
Ukraine
United Arab Emirates
United Kingdom
Vietnam
Certificates: 
EU GMP
Achievements: 
EU GMP, SFDA, JFDA, UAE, Canada, Philippines, Russia, Ukraine, Turkey, Korea, Israel, Vietnam, Taiwan GMP approvals
Head of the Company
Name, surname: 
Mr Iskandar Ismagilov
Position: 
Chairman of the Board
Contact Information
Address: 
Rupnicu Street 4, Olaine, LV2114, Latvia
Phone: 
+371-67069889
E-mail: 
ilze.prikule [at] pharmidea.lv
Contact persons' name, surname: 
Ilze Prikule
Contact persons' position: 
Busines Development and Sales manager
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Out-licensing, manufacturing, co-development and co-manufacturing, CTD, technology transfer, services related to finished dosage forms packaging, serialization

Target export countries: 
Australia
Canada
New Zealand
Singapore
Cooperation interests: 

Out-licensing of own sterile drugs, development and manufacturing of sterile niche injectables, technology transfer

SPODRA SIA

General Information
Brand name: 
SPODRA, MidoPharm
Registration number: 
40003941352
Year of foundation: 
2007
Industry (NACE 2): 
MANUFACTURING
20 Manufacture of chemicals and chemical products
20.2 Manufacture of pesticides and other agrochemical products
20.20 Manufacture of pesticides and other agrochemical products
20.4 Manufacture of soap and detergents, cleaning and polishing preparations, perfumes and toilet preparations
20.41 Manufacture of soap and detergents, cleaning and polishing preparations
20.42 Manufacture of perfumes and toilet preparations
20.5 Manufacture of other chemical products
20.59 Manufacture of other chemical products n.e.c.
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1 Manufacture of basic pharmaceutical products
21.10 Manufacture of basic pharmaceutical products
21.2 Manufacture of pharmaceutical preparations
21.20 Manufacture of pharmaceutical preparations
Number of employees: 
11 - 20
Turnover (EUR):
300 001 - 400 000
2019
200 001 - 300 000
2018
Export volume (EUR):
100 001 - 500 000
2019
50 001 - 100 000
2018
Export countries: 
Belgium
Brazil
China
Czech Republic
Estonia
France
Germany
Greece
Hong Kong
Lithuania
Saudi Arabia
Spain
Ukraine
United Kingdom
Certificates: 
ISO 9001, EN
Head of the Company
Name, surname: 
Valentins Mucenieks
Position: 
member of the board
Contact Information
Address: 
Lubanas 17-9 Riga, LV-1019 LATVIA
Phone: 
+371-29624524
E-mail: 
rikra [at] sveiks.lv
Skype name: 
valentinooo2004
Contact persons' name, surname: 
Valentins Mucenieks
Contact persons' position: 
member of the board
Languages spoken : 
English
Latvian
Russian

RIGVIR

General Information
Registration number: 
40103763354
Year of foundation: 
2014
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1 Manufacture of basic pharmaceutical products
21.10 Manufacture of basic pharmaceutical products
PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES
70 Activities of head offices; management consultancy activities
70.1 Activities of head offices
70.10 Activities of head offices
70.2 Management consultancy activities
70.21 Public relations and communication activities
70.22 Business and other management consultancy activities
Number of employees: 
11 - 20
Turnover (EUR):
300 001 - 400 000
2020
400 001 - 500 000
2019
Export volume (EUR):
No data
2020
No data
2019
Export countries: 
Australia
Canada
United Kingdom
United States of America
Certificates: 
RIGVIR is registered in 4 countries (LV;GR;ARM;UZB);
Head of the Company
Name, surname: 
Mr Jurģis Auziņš - Member of the Board
Contact Information
Address: 
Teātra iela 9 - 7, Rīga, LV-1050, Latvia
E-mail: 
rigvir [at] rigvir.com
Contact persons' name, surname: 
Mr Jurģis Auziņš - Member of the Board
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

RIGVIR represents group of companies that produce and develop oncolytic virotherapy medicines containing ECHO7 - Live oncolytic and oncotropic virus with immunomodulation activity for cancer treatment. Leading agent - RIGVIR - is approved for treatment of Melanoma skin cancer.

Cooperation interests: 

We are looking for partner who could facilitate development of our treatment agents both as an collaborative R&D partner or investor in order to successfully commercialise the drug globally.

PRIMEA

General Information
Registration number: 
40103252784
Year of foundation: 
2009
Industry (NACE 2): 
MANUFACTURING
10 Manufacture of food products
10.8 Manufacture of other food products
10.86 Manufacture of homogenised food preparations and dietetic foo
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1 Manufacture of basic pharmaceutical products
WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES
46 Wholesale trade, except of motor vehicles and motorcycles
Number of employees: 
1-10
Turnover (EUR):
4 000 001 - 5 000 000
2018
2 000 001 - 3 000 000
2017
Export volume (EUR):
2 000 001 - 3 000 000
2018
1 000 001 - 2 000 000
2017
Export countries: 
Azerbaijan
Kazakhstan
other
Certificates: 
HACCP
Head of the Company
Name, surname: 
Mr Viktors Karpovs, Mr Pāvels Meļņičonoks - Members of the Board
Contact Information
Address: 
Ģertrūdes iela 7, Rīga, LV-1010, Latvia
Phone: 
+371-67533953
Fax: 
+371-67533963
E-mail: 
primea [at] primea.eu
Contact persons' name, surname: 
Mr Viktors Karpovs, Mr Pāvels Meļņičonoks - Members of the Board
Languages spoken : 
English
German
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Latvian manufacturer of food supplements and cosmetics.

Extensive range of finished products.

We offer exclusive, complete contract-manufacturing services in capsulation, tabletting, blistering, packing and labelling.

We are innovative and flexible

Target export countries: 
Azerbaijan
Kazakhstan
Cooperation interests: 

Primea has the capacity to be a contract manufacturer for many customers in the pharmacy, health and food industries. From design to production

NORTHERN SYNTHESIS

General Information
Registration number: 
40003264804
Year of foundation: 
1995
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1 Manufacture of basic pharmaceutical products
21.10 Manufacture of basic pharmaceutical products
Number of employees: 
51 - 100
Turnover (EUR):
2 000 001 - 3 000 000
2018
2 000 001 - 3 000 000
2017
Export volume (EUR):
2 000 001 - 3 000 000
2018
2 000 001 - 3 000 000
2017
Export countries: 
Germany
Poland
Russia
Slovenia
Ukraine
other
Certificates: 
ISO 9001, GMP, Licence for narcotic drugs
Head of the Company
Name, surname: 
Mr Ēriks Masteiko - Member of the Board
Contact Information
Address: 
Ģertrūdes iela 15/17, Rīga, LV-1011, Latvia
Phone: 
+371-67270124
Fax: 
+371-67272602
E-mail: 
info [at] northernsynthesis.com
Contact persons' name, surname: 
Mr Ēriks Masteiko - Member of the Board
Languages spoken : 
English
German
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

Manufacture of active pharmaceutical ingredients (API), fine chemicals and food supplements. Contract manufacturing and contract packaging activities.
 

Target export countries: 
Germany
Poland
Russia
Slovenia
Ukraine
Cooperation interests: 

Contract manufacturing.

PHARMIDEA

General Information
Registration number: 
40003791173
Year of foundation: 
2005
Industry (NACE 2): 
MANUFACTURING
21 Manufacture of basic pharmaceutical products and pharmaceutical preparations
21.1 Manufacture of basic pharmaceutical products
21.10 Manufacture of basic pharmaceutical products
Number of employees: 
51 - 100
Turnover (EUR):
5 000 001 - 10 000 000
2019
5 000 001 - 10 000 000
2018
Export volume (EUR):
3 000 001 - 4 000 000
2019
3 000 001 - 4 000 000
2018
Export countries: 
Chile
Colombia
Croatia
Czech Republic
Estonia
Germany
Guatemala
Israel
Jordan
Lithuania
Mexico
Netherlands
Russia
Switzerland
Turkey
Ukraine
United Kingdom
Certificates: 
GMP
Head of the Company
Name, surname: 
Mr Iskandar Ismagilov
Position: 
Chairman of the Board
Contact Information
Address: 
Rūpnīcu iela 4, Olaine, Olaines nov., LV-2114, Latvia
Phone: 
+371-67069889
Fax: 
+371-67069889
E-mail: 
pharmidea [at] pharmidea.lv
Contact persons' name, surname: 
Mr Iskandar Ismagilov
Contact persons' position: 
Chairman of the Board
Languages spoken : 
English
Latvian
Russian
Business Profile and Cooperation Interests
Business profile: 

PharmIdea provides contract development and small-batch contract manufacturing of sterile products in vials, in lyophilised and liquid forms.

The company’s services also include technology development, validation, elaboration of specifications and test methods, stability studies, as well as all other documentation development for process or product registration.

PharmIdea also provides contract manufacturing of investigational medical products (IMP) for phase I to III clinical trials. Products: Atosiban, Zoledronic acid, Bendamustine, Bortezomib.
 

Target export countries: 
Chile
Colombia
Croatia
Czech Republic
Estonia
Germany
Guatemala
Israel
Jordan
Lithuania
Mexico
Netherlands
Russia
Switzerland
Turkey
Ukraine
United Kingdom
Cooperation interests: 

PharmIdea offers the contract manufacturing of cyto-toxic solutions and freeze-dried products including laboratory-scale formulation batches, small-scale batches and clinical-trial materials. PharmIdea develops sterile oncology drugs and carries out validation techniques on sterile liquids and freeze-dried vials.

Subscribe to 21.1 Manufacture of basic pharmaceutical products